Jinghua Pharmaceutical Group Co., Ltd. (SHE:002349)
China
· Delayed Price · Currency is CNY 7.51
+0.20 (2.74%)
Apr 30, 2026, 10:55 AM CST
SHE:002349 Revenue
In the year 2025, Jinghua Pharmaceutical Group had annual revenue of 1.46B CNY with 4.13% growth. Jinghua Pharmaceutical Group had revenue of 367.67M in the quarter ending December 31, 2025, with 3.01% growth.
Revenue
1.46B
Revenue Growth
+4.13%
P/S Ratio
4.15
Revenue / Employee
979.84K
Employees
1,490
Market Cap
6.06B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 1.46B | 57.87M | 4.13% |
| Dec 31, 2024 | 1.40B | -109.66M | -7.25% |
| Dec 31, 2023 | 1.51B | -61.31M | -3.90% |
| Jan 1, 2023 | 1.57B | 215.19M | 15.85% |
| Jan 1, 2022 | 1.36B | 76.51M | 5.97% |
| Dec 31, 2020 | Pro | Pro | Pro |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Shanghai Kaibao Pharmaceutical CO.,Ltd | 1.17B |
| Guizhou Xinbang Pharmaceutical | 5.62B |
| ChengDu ShengNuo Biotec | 801.40M |
| ChengDa Pharmaceuticals | 374.46M |
| Heilongjiang ZBD Pharmaceutical | 1.59B |
| Tibet Duo Rui Pharmaceutical | 177.11M |
| Chongqing Pharscin Pharmaceutical | 827.14M |
| Jiangsu Lianhuan Pharmaceutical | 2.71B |